Formulations of Bendamustine | Patent Number 11872214

US 11872214 B2
Application Number18081251
Publication NumberUS 20230115693 A1
Pendency1 year, 1 month, 3 days
Filled DateDec 14, 2022
Priority DateJan 28, 2010
Publication DateApr 13, 2023
Expiration DateJan 27, 2030
Inventor/ApplicantsNagesh R. Palepu
Philip Christopher Buxton
ExaminesARNOLD, ERNST V
Art Unit1613
Technology Center1600
Assignments
Eagle Pharmaceuticals Inc.
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.